Although genetic susceptibility explains the clustering of multiple sclerosis (MS) within
families and the sharp decline in risk with increasing genetic distance, it cannot fully explain …

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, and degenerative disease
that affects the central nervous system. A recent study showed that interaction between the …

Importance It remains unclear whether vitamin D insufficiency, which is common in
individuals with multiple sclerosis (MS), has an adverse effect on MS outcomes. Objectives …

Vitamin D system comprises hormone precursors, active metabolites, carriers, enzymes, and
receptors involved in genomic and non-genomic effects. In addition to classical bone-related …

Multiple sclerosis (MS) is an inflammatory and neurodegenerative demyelinating disease of
the central nervous system (CNS), most likely autoimmune in origin, usually beginning in …

Objective In the phase II, randomized, double-blind, placebo-controlled Supplementation of
Vigantol Oil versus Placebo Add-on in Patients with Relapsing-Remitting Multiple Sclerosis …

Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature
of relapsing-remitting multiple sclerosis (MS), the most prevalent MS phenotype. While their …

Background This review is an update of a previously published review," Vitamin D for the
management of multiple sclerosis"(published in the Cochrane Library; 2010, Issue 12) …

The Canadian Multiple Sclerosis Working Group (CMSWG) developed practical
recommendations in 2004 to assist clinicians in optimizing the use of disease-modifying …

Objective: To study the safety profile and characterize the immunologic effects of high-vs low-
dose cholecalciferol supplementation in patients with multiple sclerosis (MS). Methods: In …